US6605448B1
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method and means for sorting and identifying biological information
Assignee: DR GEORGE PIECZENIK
•
Filing: 1998-11-18
•
Granted: 2003-08-12
•
Expires: 2018-11-18
Abstract
Abstract In one aspect the invention discloses a matrix comprising a discrete population of random oligopeptides of the same length, the length being selected from about 4 to about 12 L-amino acid residues, the population comprising at least 10% of all amino acid sequences of the selected length; and a heterogeneous population of antibodies comprising antibodies capable of binding to substantially every member of the oligopeptide population.
Inventors
- 👤 George Pieczenik
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 09:56
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; C; C07; C07K; C07K16/00; C07K16/005; C07K16/18; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C12Q; C12Q1/00; C12Q1/68; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/68; G01N33/6878
Claims Analysis
Total Claims: 27
Claim 1
Independent Claim
135 words
A population of recombinant vectors comprising: a population of filamentous bacteriophage wherein each filamentous bacteriophage comprises a recombinant structural gene wherein each structural gene comprises an insert consisting of one member of an oligonucleotide population and wherein the population of filamentous bacteriophage comprise a plurality of different members of the oligonucleotide population, said oligonucleotide population comprising oligonucleotides comprising a coding region consisting of a length from about 4 to about 12 nucleotide triplets, said oligonucleotide population encoding a plurality of corresponding random peptide sequences from about 4 to about 12 L-amino acid residues, and wherein said recombinant structural genes are expressed upon transfer of said recombinant vectors into Escherichia coli host cells, and wherein expression of the recombinant structural genes yields polypeptides, each poly peptide comprising one of said plurality of corresponding random peptide sequences.
Claim 2
Dependent Claim
135 words
A population of recombinant vectors comprising: a population of filamentous bacteriophage wherein each filamentous bacteriophage comprises a recombinant structural gene wherein each structural gene comprises an insert consisting of one member of an oligonucleotide population and wherein the population of filamentous bacteriophage comprise a plurality of different members of the oligonucleotide population, said oligonucleotide population comprising oligonucleotides comprising a coding region consisting of a length from about 4 to about 12 nucleotide triplets, said oligonucleotide population encoding a plurality of corresponding random peptide sequences from about 4 to about 12 L-amino acid residues, and wherein said recombinant structural genes are expressed upon transfer of said recombinant vectors into Escherichia coli host cells, and wherein expression of the recombinant structural genes yields polypeptides, each poly peptide comprising one of said plurality of corresponding random peptide sequences.
Claim 3
Dependent Claim
64 words
The vector population of claim 1 wherein each of the encoded corresponding peptides forms a binding pair with an antibody that has not been elicited by immunization with said peptide or said peptide in conjugated form, said antibody being selected from the group consisting of all antibodies produced by lymphoid-derived antibody-producing cells, where the group of all antibodies together recognizes substantially all epitopic sequences.
Claim 4
Dependent Claim
45 words
The recombinant vector population of claim 1 , wherein each of said members of said oligonucleotide population has a length of from about 4 to 7 nucleotide triplets and the encoded corresponding peptide sequences have a length of from 4 to 7 L-amino acid residues.
Claim 5
Dependent Claim
42 words
The recombinant vector population of claim 1 , wherein each of said members of said oligonucleotide population has a coding region having a length of 4 nucleotide triplets and the encoded corresponding peptide sequence has a length of 4 amino acid residues.
Claim 6
Dependent Claim
38 words
The recombinant vector population of claim 1 , wherein each of said members of said oligonucleotide population has a length of 5 nucleotide triplets and the encoded corresponding peptide sequences have a length of 5 L-amino acid residues.
Claim 7
Dependent Claim
42 words
The recombinant vector population of claim 1 , wherein each of said members of said oligonucleotide population has a coding region having a length of 6 nucleotide triplets and the encoded corresponding peptide sequence has a length of 6 amino acid residues.
Claim 8
Dependent Claim
42 words
The recombinant vector population of claim 1 , wherein each of said members of said oligonucleotide population has a coding region having a length of 7 nucleotide triplets and the encoded corresponding peptide sequence has a length of 7 amino acid residues.
Claim 9
Dependent Claim
42 words
The recombinant vector population of claim 1 , wherein each of said members of said oligonucleotide population has a coding region having a length of 8 nucleotide triplets and the encoded corresponding peptide sequence has a length of 8 amino acid residues.
Claim 10
Dependent Claim
42 words
The recombinant vector population of claim 1 , wherein each of said members of said oligonucleotide population has a coding region having a length of 9 nucleotide triplets and the encoded corresponding peptide sequence has a length of 9 amino acid residues.
Claim 11
Dependent Claim
42 words
The recombinant vector population of claim 1 , wherein each of said members of said oligonucleotide population has a coding region having a length of 10 nucleotide triplets and the encoded corresponding peptide sequence has a length of 10 amino acid residues.
Claim 12
Dependent Claim
42 words
The recombinant vector population of claim 1 , wherein each of said members of said oligonucleotide population has a coding region having a length of 11 nucleotide triplets and the encoded corresponding peptide sequence has a length of 11 amino acid residues.
Claim 13
Dependent Claim
42 words
The recombinant vector population of claim 1 , wherein each of said members of said oligonucleotide population has a coding region having a length of 12 nucleotide triplets and the encoded corresponding peptide sequence has a length of 12 amino acid residues.
Claim 14
Dependent Claim
13 words
The recombinant vector population of claim 1 wherein said filamentous bacteriophage are f1.
Claim 15
Dependent Claim
13 words
The recombinant vector population of claim 1 wherein said filamentous bacteriophage are fd.
Claim 16
Dependent Claim
13 words
The recombinant vector population of claim 1 wherein said filamentous bacteriophage are M13.
Claim 17
Dependent Claim
32 words
The recombinant vector population of claim 1 wherein the sum of corresponding peptide sequences encoded by said oligonucleotide population represents at least about 10% of all possible peptide sequences of said length.
Claim 18
Dependent Claim
29 words
The recombinant vector population of claim 1 wherein the sum of the corresponding peptide sequences encoded by said oligonucleotide population includes substantially all possible peptide sequences of said length.
Claim 19
Independent Claim
153 words
A method of producing a population of epitopic peptide sequences, comprising: Providing a population of recombinant Escherichia coli cells, each of said cells containing at least one member of a recombinant vector population, each member of said vector population comprising filamentous bacteriophage, wherein each filamentous bacteriophage comprises a recombinant structural gene wherein each structural gene comprises an insert consisting of one member of an oligonucleotide population and wherein the population of filamentous bacteriophage comprise a plurality of different members of the oligonucleotide population, said oligonucleotide population comprising oligonucleotides comprising a coding region consisting of a length from about 4 to about 12 nucleotides triplets, said oligonucleotide population encoding a plurality of epitopic peptides consisting of random sequences of from about 4 to about 12 L-amino acid residues: and Culturing said recombinant Escherichia coli cells to allow expression of said recombinant structural genes such that said epitopic peptide sequences are accessible to antibody recognition.
Claim 20
Independent Claim
153 words
A method of producing a population of epitopic peptide sequences, comprising: Providing a population of recombinant Escherichia coli cells, each of said cells containing at least one member of a recombinant vector population, each member of said vector population comprising filamentous bacteriophage, wherein each filamentous bacteriophage comprises a recombinant structural gene wherein each structural gene comprises an insert consisting of one member of an oligonucleotide population and wherein the population of filamentous bacteriophage comprise a plurality of different members of the oligonucleotide population, said oligonucleotide population comprising oligonucleotides comprising a coding region consisting of a length from about 4 to about 12 nucleotides triplets, said oligonucleotide population encoding a plurality of epitopic peptides consisting of random sequences of from about 4 to about 12 L-amino acid residues: and Culturing said recombinant Escherichia coli cells to allow expression of said recombinant structural genes such that said epitopic peptide sequences are accessible to antibody recognition.
Claim 21
Dependent Claim
23 words
The method of claim 18 wherein the sum of said corresponding epitopic peptide sequences represents substantially all possible peptide sequences of said length.
Claim 22
Dependent Claim
27 words
The method of claim 18 wherein the sum of said corresponding epitopic peptide sequences represents at least about 10% of all possible peptide sequences of said length.
Claim 23
Dependent Claim
56 words
The method of claim 20 wherein said oligonucleotide population encodes a number of peptide sequences of said length having sufficient conformational similarity with an antibody binding site of a test species such that an antibody that binds to the antibody binding site of the test species also binds a peptide of the encoded plurality of peptides.
Claim 24
Dependent Claim
145 words
A population of recombinant vectors comprising substantially identical autonomously replicating nucleic acid sequences comprising a recombinant structural gene, each structural gene having inserted therein a member of an oligonucleotide population, wherein each member of said oligonucleotide population comprises a coding region comprising a length from about 4 to about 12 nucleotide triplets that encodes a corresponding peptide sequence of from about 4 to about 12 L-amino acid residues, and wherein the sum of corresponding peptide sequences encoded by said oligonucleotide population represents at least about 10% of all possible peptide sequences of said length, and wherein each member of said oligonucleotide population is contained in said recombinant vector population, and wherein the recombinant structural genes are expressed upon transfer of said recombinant vectors into Escherichia coli host cells, and wherein expression of said recombinant structural genes yields polypeptides, each polypeptide comprising said corresponding peptide sequence.
Claim 25
Dependent Claim
145 words
A population of recombinant vectors comprising substantially identical autonomously replicating nucleic acid sequences comprising a recombinant structural gene, each structural gene having inserted therein a member of an oligonucleotide population, wherein each member of said oligonucleotide population comprises a coding region comprising a length from about 4 to about 12 nucleotide triplets that encodes a corresponding peptide sequence of from about 4 to about 12 L-amino acid residues, and wherein the sum of corresponding peptide sequences encoded by said oligonucleotide population represents at least about 10% of all possible peptide sequences of said length, and wherein each member of said oligonucleotide population is contained in said recombinant vector population, and wherein the recombinant structural genes are expressed upon transfer of said recombinant vectors into Escherichia coli host cells, and wherein expression of said recombinant structural genes yields polypeptides, each polypeptide comprising said corresponding peptide sequence.
Claim 26
Independent Claim
173 words
A method of producing a population of epitopic peptide sequences, comprising the steps of: Providing a population of recombinant E. coli cells, each of said cells containing at least one member of a recombinant vector population, each member of said vector population comprising substantially identical autonomously replicating nucleic acid sequences, said nucleic acid sequences comprising a recombinant structural gene, each structural gene having inserted therein a member of an oligonucleotide population wherein each member of said oligonucleotide population comprises a coding region comprising a length from about 4 to about 12 nucleotide triplets that encodes a corresponding peptide sequence of from about 4 to about 12 L-amino acid residues, and wherein each member of said oligonucleotide population is contained in said recombinant vector population and wherein the sum of said corresponding epitopic peptide sequences represents at least about 10% of all possible peptide sequences of said length: and culturing said recombinant E. coli cells to allow expression of said recombinant structural genes such that said epitopic peptide sequences are accessible to antibody recognition.
Claim 27
Independent Claim
173 words
A method of producing a population of epitopic peptide sequences, comprising the steps of: Providing a population of recombinant E. coli cells, each of said cells containing at least one member of a recombinant vector population, each member of said vector population comprising substantially identical autonomously replicating nucleic acid sequences, said nucleic acid sequences comprising a recombinant structural gene, each structural gene having inserted therein a member of an oligonucleotide population wherein each member of said oligonucleotide population comprises a coding region comprising a length from about 4 to about 12 nucleotide triplets that encodes a corresponding peptide sequence of from about 4 to about 12 L-amino acid residues, and wherein each member of said oligonucleotide population is contained in said recombinant vector population and wherein the sum of said corresponding epitopic peptide sequences represents at least about 10% of all possible peptide sequences of said length: and culturing said recombinant E. coli cells to allow expression of said recombinant structural genes such that said epitopic peptide sequences are accessible to antibody recognition.
References Cited (Backward Citations)
US4237224A
Cited
US4196265A
Cited
US4172124A
Cited
DD143794A1
Cited
US4528266A
Cited
US4359535A
Cited
GB2068971A
Cited
US4423147A
Cited
EP0048470A2
Cited
EP0098118A1
Cited
WO1984000687A1
Cited
US4625015A
Cited
DE3300632A1
Cited
WO1984002922A1
Cited
WO1984003506A1
Cited
WO1984003564A1
Cited
US4708871A
Cited
EP0135277A1
Cited
WO1985000807A1
Cited
EP0154186A2
Cited
WO1985003725A1
Cited
EP0157643A2
Cited
US4618578A
Cited
US5194392A
Cited
WO1986000991A1
Cited
GB2183661A
Cited
US5723323A
Cited
WO1986006487A1
Cited
US4833092A
Cited
US5866363A
Cited
US5223409A
Cited
US5539084A
Cited
WO1990015070A1
Cited
US5698426A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2006-08-11 | 2007-02-10 | 2007-08-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2010-08-11 | 2011-02-10 | 2011-08-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2014-08-11 | 2015-02-10 | 2015-08-12 | $7700.00 | Window Closed / Lapsed |